Advanced Oncotherapy (AVO) today said it could receive the initial tranche of funding from its recapitalisation plan this month. Following ‘unexpected delays’ with its third-party investor, the proton beam therapy developer said a first tranche of funding in the region of $15m is expected in February. AVO entered into a non-binding agreement with the investor…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
 today said it could receive the initial tranche of funding from its recapitalisation plan this month.){kind=link}